Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.
暂无分享,去创建一个
Pier D. Lambiase | Kenneth M. Stein | Michael R. Gold | P. Lambiase | M. Gold | B. Knight | R. Weiss | A. León | D. Theuns | K. Stein | L. Boersma | R. Knops | J. Herre | M. Burke | Martin C. Burke | Angel R. Leon | Raul Weiss | Michael Husby | C. Barr | John M. Herre | Bradley P. Knight | Reinoud E. Knops | Craig S. Barr | Dominic A. M. J. Theuns | Lucas V. A. Boersma | M. Husby
[1] A. Go,et al. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. , 2013, JAMA.
[2] A. Wilde,et al. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management. , 2014, Heart rhythm.
[3] J. Pogue,et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE) , 2015, The Lancet.
[4] P. Heidenreich,et al. Physician Procedure Volume and Complications of Cardioverter-Defibrillator Implantation , 2012, Circulation.
[5] Wojciech Zareba,et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.
[6] C. Israel,et al. Electrical Storm in Patients with an Implanted Defibrillator: A Matter of Definition , 2007, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[7] Michael O. Sweeney,et al. Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.
[8] Wojciech Zareba,et al. Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.
[9] A. Moss,et al. Clinical Impact, Safety, and Efficacy of Single‐ versus Dual‐Coil ICD Leads in MADIT‐CRT , 2013, Journal of cardiovascular electrophysiology.
[10] P. Lambiase,et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry , 2014, European heart journal.
[11] Martin J Schalij,et al. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. , 2011, Journal of the American College of Cardiology.
[12] M. Gold,et al. Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study , 2012, Journal of cardiovascular electrophysiology.
[13] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[14] M. Gold,et al. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing. , 2013, Circulation. Arrhythmia and electrophysiology.
[15] Nora Toma,et al. An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, Maedica.
[16] A. Wilde,et al. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. , 2013, Heart rhythm.
[17] M. Gold,et al. Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation: Primary Results From the Low Energy Safety Study (LESS) , 2002, Circulation.
[18] D. Hayes,et al. Impact of shock energy and ventricular rhythm on the success of first shock therapy: the ALTITUDE first shock study. , 2013, Heart rhythm.
[19] M. Keller,et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.
[20] Alexander H Maass,et al. An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.
[21] Mark Kremers,et al. Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator , 2013, Circulation.
[22] L. Jordaens,et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.
[23] M. Gold,et al. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator. , 2014, Heart rhythm.
[24] A. Russo,et al. The Dilemma of ICD Implant Testing , 2007, Pacing and clinical electrophysiology : PACE.